![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Obinutuzumab bests rituximab for PFS in follicular lymphoma (MDedge: news and insights for busy physicians) View |
![]() |
Obinutuzumab extends PFS for follicular lymphoma in GALLIUM trial (ecancer) View |
![]() |
Debate: Is obinutuzumab superior to rituximab in lymphoma - No (HMP Education) View |
![]() |
Robert E. Marcus, MD: GALLIUM Study of Obinutuzumab in Untreated Follicular Lymphoma (American Society of Hematology) View |
![]() |
Debate: Is obinutuzumab superior to rituximab in lymphoma - Yes (HMP Education) View |
![]() |
Obinutuzumab Extends Remission Time in Rituximab-Refractory iNHL (American Society of Hematology) View |
![]() |
Debate: Best upfront therapy for advanced follicular lymphoma - Obinutuzumab-based therapy (HMP Education) View |
![]() |
Obinutuzumab for Indolent Lymphoma (OncLive) View |
![]() |
Upfront Therapy Strategies in Follicular Lymphoma (OncLive) View |
![]() |
obinutuzumab plus bendamustine in rituximab-refractory indolent non-Hodgkin lymphoma (Oncoletter) View |